Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation

被引:69
|
作者
Elfadawy, Nissreen [1 ]
Flechner, Stuart M. [1 ]
Schold, Jesse D. [2 ]
Srinivas, Titte R. [4 ]
Poggio, Emilio [1 ]
Fatica, Richard [1 ]
Avery, Robin [5 ]
Mossad, Sherif B. [3 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Infect Dis, Inst Med, Cleveland, OH 44106 USA
[4] Med Univ S Carolina, Div Nephrol, Charleston, SC 29425 USA
[5] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 03期
关键词
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY; RENAL-TRANSPLANTATION; VIRUS NEPHRITIS; VIRAL LOAD; RECIPIENTS; INFECTION; ALLOGRAFT; REPLICATION; PCR;
D O I
10.2215/CJN.08420813
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The objective was to study the long-term impact of transient versus persistent BK viremia on kidney transplant outcomes. Design, setting, participants, & measurements In total, 609 recipients who underwent kidney transplant from 2007 to 2011 were screened at months 1-12 for the occurrence of polyomavirus BK viremia; 130 patients (21.7%) developed BK viremia during the first year post-transplant. BK viremia patients were classified according to duration of infection (more or less than 3 months), and BK viral loads (more or less than 10,000 copies/ml) were classified as transient low viremia (n=42), transient high viremia (n=18), persistent low viremia (n=23), and persistent high viremia (n=47). All patients were followed a median of 36 (3-66) months. The rates of BK polyomavirus-associated nephropathy, acute rejection, and 1-year graft function were compared with the polyomavirus BK-negative control group. Results Patient and graft survival were not significantly different among the groups. Graft function (creatinine; milligrams per deciliter) at 1 year was significantly worse in the persistent high viremia (1.75 +/- 0.6) and transient high viremia (1.85 +/- 0.7) groups compared with aviremic controls (1.47 +/- 0.4; P=0.01 and P=0.01, respectively). The incidence of BK polyomavirus-associated nephropathy was limited to the persistent high viremia group (1.3%, P<0.001). The transient high viremia (50%) and persistent high viremia (34%) groups showed significantly (P=0.01) increased incidence of acute rejection versus aviremic controls (21.5%), transient low viremia (19%), or persistent low viremia (17.3%) groups. Conclusion Low viral load BK viremia, either transient or persistent, was not associated with long-term transplant outcomes. Persistent high viremia was associated with a greater risk for BK polyomavirus-associated nephropathy and subsequent graft dysfunction. Although transient high viremia was not associated with BK polyomavirus-associated nephropathy, it was associated with worse graft function. These data support the role of surveillance for BK viremia after transplant.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [1] Outcomes after simultaneous kidney-pancreas versus pancreas after kidney transplantation in the current era
    Parajuli, Sandesh
    Arunachalam, Annamalai
    Swanson, Kurtis J.
    Aziz, Fahad
    Garg, Neetika
    Redfield, Robert R.
    Kaufman, Dixon
    Djamali, Arjang
    Odorico, Jon
    Mandelbrot, Didier A.
    CLINICAL TRANSPLANTATION, 2019, 33 (12)
  • [2] CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation
    Elfadawy, Nissreen
    Flechner, Stuart M.
    Liu, Xiaobo
    Schold, Jesse
    Srinivas, Titte R.
    Poggio, Emilio
    Fatica, Richard
    Avery, Robin
    Mossad, Sherif B.
    TRANSPLANTATION, 2013, 96 (12) : 1097 - 1103
  • [3] Antiviral treatment of BK virus viremia after kidney transplantation
    Santeusanio, Andrew D.
    Lukens, Benjamin E.
    Eun, Judy
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (24) : 2037 - 2045
  • [4] Outcomes of Pancreas Retransplantation After Simultaneous Kidney-Pancreas Transplantation Are Comparable to Pancreas After Kidney Transplantation Alone
    Seal, John
    Selzner, Markus
    Laurence, Jerome
    Marquez, Max
    Bazerbachi, Fateh
    McGilvray, Ian
    Schiff, Jeffrey
    Norgate, Andrea
    Cattral, Mark S.
    TRANSPLANTATION, 2015, 99 (03) : 623 - 628
  • [5] Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients
    Imlay, Hannah
    Whitaker, Kathryn
    Fisher, Cynthia E.
    Limaye, Ajit P.
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (04)
  • [6] BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients
    Westphal, Scott G.
    Lyden, Elizabeth R.
    Langewisch, Eric D.
    Miles, Clifford D.
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [7] Acute diarrhea after kidney or kidney-pancreas transplantation
    Carena, Alberto A.
    Boughen, Santiago
    Ines Gagliardi, Maria
    Galante, Mariana
    MEDICINA-BUENOS AIRES, 2015, 75 (01) : 29 - 36
  • [8] Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia
    Knight, Richard J.
    Graviss, Edward A.
    Nguyen, Duc T.
    Kuten, Samantha A.
    Patel, Samir J.
    Gaber, Lillian
    Gaber, A. Osama
    CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [9] Clostridium difficile colitis after kidney and kidney-pancreas transplantation
    West, M
    Pirenne, J
    Chavers, B
    Gillingham, K
    Sutherland, DER
    Dunn, DL
    Matas, AJ
    CLINICAL TRANSPLANTATION, 1999, 13 (04) : 318 - 323
  • [10] Comparison of the long-term outcomes of kidney transplantation: USA versus Spain
    Ojo, Akinlolu O.
    Maria Morales, Jose
    Gonzalez-Molina, Miguel
    Steffick, Diane E.
    Luan, Fu L.
    Merion, Robert M.
    Ojo, Tammy
    Moreso, Francesc
    Arias, Manuel
    Maria Campistol, Josep
    Hernandez, Domingo
    Seron, Daniel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (01) : 213 - 220